GPRO agrees to buy British diagnostic test company Tepnel for $132.2M in cash. Gen-Probe's offer represents a 126% premium to Tepnel's closing price per share on Jan. 21.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.